Publications of Hannelore Ehrenreich
All genres
Journal Article (245)
141.
Journal Article
18 (4), pp. 628 - 635 (2012)
Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Molecular Medicine 142.
Journal Article
17 (3), pp. 237 - 239 (2012)
BACE1 in central nervous system myelination revisited. Molecular Psychiatry 143.
Journal Article
32 (9), pp. 2915 - 2930 (2012)
5-HT₇R/G₁₂ signaling regulates neuronal morphology and function in an age-dependent manner. Journal of Neuroscience 144.
Journal Article
219 (3), pp. 687 - 698 (2012)
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology 145.
Journal Article
17 (11-12), pp. 1306 - 1310 (2011)
Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients. Molecular Medicine 146.
Journal Article
20 (20), pp. 4076 - 4081 (2011)
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human Molecular Genetics 147.
Journal Article
Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia. Translational Psychiatry, e45 (2011)
148.
Journal Article
21 (10), pp. 2299 - 2306 (2011)
Circadian modulation of GABA-mediated cortical inhibition. Cerebral Cortex 149.
Journal Article
68 (12), pp. 1247 - 1256 (2011)
Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Archives of General Psychiatry 150.
Journal Article
9, 27 (2011)
Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biology 151.
Journal Article
156 (3), pp. 340 - 345 (2011)
A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 152.
Journal Article
3 (6), pp. 309 - 319 (2011)
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. Embo Molecular Medicine 153.
Journal Article
35 (10), pp. 1732 - 1736 (2011)
Supervised disulfiram in the treatment of alcohol use disorder: a commentary. Alcoholism: Clinical and Experimental Research 154.
Journal Article
188, pp. 95 - 108 (2011)
Erythropoietin promotes survival and regeneration of insect neurons in vivo and in vitro. Neuroscience 155.
Journal Article
11 (2), pp. 261 - 269 (2011)
Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics 156.
Journal Article
16 (1), pp. 26 - 36 (2011)
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Molecular Psychiatry 157.
Journal Article
16, 1 (2011)
EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process. Molecular Psychiatry 158.
Journal Article
10, 91 (2010)
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 159.
Journal Article
11 (1), 97 (2010)
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials 160.
Journal Article
11, 118 (2010)
Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neuroscience